ArticleOncoimmunology

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.

Chiara Riganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.